SOLUNA HOLDINGS INC (SLNH) Fundamental Analysis & Valuation

NASDAQ:SLNH • US5835433013

0.793 USD
+0.04 (+5.72%)
At close: Mar 10, 2026
0.7955 USD
+0 (+0.32%)
After Hours: 3/10/2026, 8:00:03 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This SLNH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

SLNH gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 277 industry peers in the Software industry. SLNH may be in some trouble as it scores bad on both profitability and health. SLNH is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. SLNH Profitability Analysis

1.1 Basic Checks

  • In the past year SLNH has reported negative net income.
  • In the past year SLNH has reported a negative cash flow from operations.
  • SLNH had negative earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: SLNH reported negative operating cash flow in multiple years.
SLNH Yearly Net Income VS EBIT VS OCF VS FCFSLNH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

  • The Return On Assets of SLNH (-51.90%) is worse than 84.84% of its industry peers.
  • With a Return On Equity value of -545.27%, SLNH is not doing good in the industry: 86.64% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -51.9%
ROE -545.27%
ROIC N/A
ROA(3y)-73.36%
ROA(5y)-40.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SLNH Yearly ROA, ROE, ROICSLNH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for SLNH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SLNH Yearly Profit, Operating, Gross MarginsSLNH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. SLNH Health Analysis

2.1 Basic Checks

  • SLNH does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • SLNH has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, SLNH has more shares outstanding
  • Compared to 1 year ago, SLNH has a worse debt to assets ratio.
SLNH Yearly Shares OutstandingSLNH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
SLNH Yearly Total Debt VS Total AssetsSLNH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • SLNH has an Altman-Z score of -3.26. This is a bad value and indicates that SLNH is not financially healthy and even has some risk of bankruptcy.
  • SLNH has a worse Altman-Z score (-3.26) than 80.87% of its industry peers.
  • A Debt/Equity ratio of 0.92 indicates that SLNH is somewhat dependend on debt financing.
  • SLNH has a worse Debt to Equity ratio (0.92) than 74.01% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF N/A
Altman-Z -3.26
ROIC/WACCN/A
WACC10.57%
SLNH Yearly LT Debt VS Equity VS FCFSLNH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

2.3 Liquidity

  • A Current Ratio of 1.18 indicates that SLNH should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.18, SLNH is not doing good in the industry: 66.06% of the companies in the same industry are doing better.
  • SLNH has a Quick Ratio of 1.18. This is a normal value and indicates that SLNH is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.18, SLNH is not doing good in the industry: 65.70% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 1.18
SLNH Yearly Current Assets VS Current LiabilitesSLNH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. SLNH Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 30.90% over the past year.
  • The Revenue for SLNH has decreased by -27.81% in the past year. This is quite bad
  • SLNH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 42.07% yearly.
EPS 1Y (TTM)30.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4.45%
Revenue 1Y (TTM)-27.81%
Revenue growth 3Y38.37%
Revenue growth 5Y42.07%
Sales Q2Q%11.83%

3.2 Future

  • SLNH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 39.77% yearly.
  • SLNH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.36% yearly.
EPS Next Y80.68%
EPS Next 2Y39.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-16.57%
Revenue Next 2Y10.36%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
SLNH Yearly Revenue VS EstimatesSLNH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M
SLNH Yearly EPS VS EstimatesSLNH Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

1

4. SLNH Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for SLNH. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SLNH. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SLNH Price Earnings VS Forward Price EarningsSLNH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SLNH Per share dataSLNH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as SLNH's earnings are expected to grow with 39.77% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.77%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SLNH Dividend Analysis

5.1 Amount

  • SLNH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SLNH Fundamentals: All Metrics, Ratios and Statistics

SOLUNA HOLDINGS INC

NASDAQ:SLNH (3/10/2026, 8:00:03 PM)

After market: 0.7955 +0 (+0.32%)

0.793

+0.04 (+5.72%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-14
Earnings (Next)03-30
Inst Owners14.92%
Inst Owner Change219.33%
Ins Owners31.33%
Ins Owner Change76.8%
Market Cap82.08M
Revenue(TTM)28.78M
Net Income(TTM)-78.91M
Analysts82.86
Price Target5.1 (543.13%)
Short Float %12.01%
Short Ratio1.78
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)67.74%
EPS NY rev (1m)0%
EPS NY rev (3m)18.72%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.92%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.12%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.85
P/FCF N/A
P/OCF N/A
P/B 5.67
P/tB 21.16
EV/EBITDA N/A
EPS(TTM)-6.15
EYN/A
EPS(NY)-0.47
Fwd EYN/A
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0.28
BVpS0.14
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -51.9%
ROE -545.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-73.36%
ROA(5y)-40.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 141.39%
Cap/Sales 77.99%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.18
Quick Ratio 1.18
Altman-Z -3.26
F-Score2
WACC10.57%
ROIC/WACCN/A
Cap/Depr(3y)126.88%
Cap/Depr(5y)534.63%
Cap/Sales(3y)102.76%
Cap/Sales(5y)154.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4.45%
EPS Next Y80.68%
EPS Next 2Y39.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-27.81%
Revenue growth 3Y38.37%
Revenue growth 5Y42.07%
Sales Q2Q%11.83%
Revenue Next Year-16.57%
Revenue Next 2Y10.36%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-95.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-39.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.89%
OCF growth 3YN/A
OCF growth 5YN/A

SOLUNA HOLDINGS INC / SLNH FAQ

Can you provide the ChartMill fundamental rating for SOLUNA HOLDINGS INC?

ChartMill assigns a fundamental rating of 2 / 10 to SLNH.


Can you provide the valuation status for SOLUNA HOLDINGS INC?

ChartMill assigns a valuation rating of 1 / 10 to SOLUNA HOLDINGS INC (SLNH). This can be considered as Overvalued.


Can you provide the profitability details for SOLUNA HOLDINGS INC?

SOLUNA HOLDINGS INC (SLNH) has a profitability rating of 0 / 10.


Can you provide the financial health for SLNH stock?

The financial health rating of SOLUNA HOLDINGS INC (SLNH) is 1 / 10.


Can you provide the expected EPS growth for SLNH stock?

The Earnings per Share (EPS) of SOLUNA HOLDINGS INC (SLNH) is expected to grow by 80.68% in the next year.